Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Psychiatry and Clinical Neurosciences|July 2, 2009
Differentiation between attention-deficit/hyperactivity disorder and pervasive developmental disorders with hyperactivity on objective activity levels using actigraphsNoa Tsujii, Akira Okada, Reigetsu Kaku, et al.Scientific Reports|March 29, 2019
Capturing spontaneous activity in the medial prefrontal cortex using near-infrared spectroscopy and its application to schizophreniaFumiharu Hosomi, Masaya Yanagi, Yoshihiro Kawakubo, et al.Plos One|April 6, 2017
Reduced left precentral regional responses in patients with major depressive disorder and history of suicide attemptsNoa Tsujii, Wakako Mikawa, Emi Tsujimoto, et al.Journal of Child and Adolescent Psychopharmacology|December 6, 2023
Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive DisorderTakuya Saito, Hidetoshi Takahashi, Noa Tsujii, et al.Psychiatry Research. Neuroimaging|June 5, 2016
Relationship between prefrontal hemodynamic responses and quality of life differs between melancholia and non-melancholic depressionNoa Tsujii, Wakako Mikawa, Emi Tsujimoto, et al.Journal of Child and Adolescent Psychopharmacology|June 24, 2015
Experiences with Patient Refusal of Off-Label Prescribing of Psychotropic Medications to Children and Adolescents in JapanNoa Tsujii, Takuya Saito, Yuji Izumoto, et al.Psychiatry and Clinical Neurosciences|September 24, 2017
An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in JapanHironobu Ichikawa, Michio Hiratani, Akihiro Yasuhara, et al.Journal of Affective Disorders|April 23, 2014
Discrepancy between self- and observer-rated depression severities as a predictor of vulnerability to suicide in patients with mild depressionNoa Tsujii, Hiroyuki Akashi, Wakako Mikawa, et al.Neurology and Therapy|June 5, 2021
Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic ReviewNoa Tsujii, Masahide Usami, Noriyuki Naya, et al.Psychiatry and Clinical Neurosciences|March 17, 2007
Association between activity level and situational factors in children with attention deficit/hyperactivity disorder in elementary schoolNoa Tsujii, Akira Okada, Reigetsu Kaku, et al.Pageof 6